Page last updated: 2024-11-03

propantheline and Acute Ischemic Stroke

propantheline has been researched along with Acute Ischemic Stroke in 1 studies

Propantheline: A muscarinic antagonist used as an antispasmodic, in rhinitis, in urinary incontinence, and in the treatment of ulcers. At high doses it has nicotinic effects resulting in neuromuscular blocking.

Research Excerpts

ExcerptRelevanceReference
"Acute ischemic stroke is a leading cause of disability and death."1.72Synthesis and biological evaluation of 1,2,4-triazole derivatives as potential Nrf2 activators for the treatment of cerebral ischemic injury. ( Chen, J; Huang, P; Jiang, C; Lao, Y; Shi, J; Su, R; Wang, Y; Zhang, J, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Lao, Y1
Wang, Y1
Chen, J1
Huang, P1
Su, R1
Shi, J1
Jiang, C1
Zhang, J1

Other Studies

1 other study available for propantheline and Acute Ischemic Stroke

ArticleYear
Synthesis and biological evaluation of 1,2,4-triazole derivatives as potential Nrf2 activators for the treatment of cerebral ischemic injury.
    European journal of medicinal chemistry, 2022, Jun-05, Volume: 236

    Topics: Animals; Heme Oxygenase-1; Ischemic Stroke; Kelch-Like ECH-Associated Protein 1; Neuroprotective Age

2022